Delivery Order SPE2DR25D3103-SPE2DR26F9T96
Award Date 1/2/26
Potential Completion Date 1/26/26
Potential Value $41K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,633.82 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 ml units. This firm fixed price delivery order, with an ultimate completion date of November 18, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's headquarters in Conshohocken, Pennsylvania. Cabenuva is a long-acting injectable antiretroviral combination therapy...
- The Defense Logistics Agency awarded a $7,633.80 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) with a firm fixed price structure and an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract represents a single delivery order executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CABENUVA is an injectable antiretroviral...
- The Defense Logistics Agency awarded a delivery order valued at $40,224.30 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) on November 13, 2025, with an ultimate completion date of December 5, 2025. This firm fixed price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $8,044.86 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) on December 22, 2025, with completion scheduled for January 14, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a $5,078.08 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 mg-600 mg suspension in 4 mL formulation, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the breadth of...
- This delivery order, valued at $22,901.40, was awarded on August 7, 2025, by the Medical Supply Chain division of the Defense Logistics Agency to AmerisourceBergen Drug Corp for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL). The award represents a firm fixed-price, non-competitive delivery order with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,169 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) on August 22, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, representing the company's...
- The Defense Logistics Agency awarded a $38,169.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), with an ultimate completion date of May 15, 2025. This non-set-aside competitive award represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension in 6 mL quantities, valued at $3,816.90. This is a firm fixed price delivery order with an ultimate completion date of July 14, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $24,134.58 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL), a long-acting injectable antiretroviral medication used in HIV treatment. The contract, awarded on November 26, 2025, with an ultimate completion date of December 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken,...